|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
20.880 +2.060 (+10.946%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -- | 7.116% | 6.818% | 7.071% | 10.965% |
| ROAE (%) | -- | 13.807% | 14.101% | 13.556% | 17.670% |
| Return on Capital Employed (%) | -- | 9.102% | 7.016% | 8.291% | 10.781% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | -- | 33.800% | 35.490% | 36.520% | 35.896% |
| EBITDA Margin (%) | -- | 28.756% | 25.977% | 25.310% | 32.719% |
| Pre-tax Profit Margin (%) | -- | 17.036% | 15.929% | 16.232% | 25.672% |
| Net Profit Margin (%) | -- | 14.609% | 13.877% | 13.389% | 22.314% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | -- | 1.801 X | 2.976 X | 1.671 X | 2.899 X |
| Quick Ratio (X) | -- | 1.686 X | 2.876 X | 1.578 X | 2.838 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | -- | 40.558% | 50.001% | 47.103% | 44.014% |
| Total Debt / Total Assets (%) | -- | 24.973% | 36.627% | 29.848% | 28.740% |
| Net Debt / Total Assets (%) | -- | 18.190% | 14.754% | 22.780% | 9.563% |
| Total Debt / Shareholders' Funds (%) | -- | 43.875% | 78.471% | 59.096% | 53.220% |
| Long Term Debt / Shareholders' Funds (%) | -- | 35.087% | 71.085% | 50.384% | 47.404% |
| Net Debt / Shareholders' Funds (%) | -- | 31.958% | 31.610% | 45.104% | 17.708% |
| Net Cash / (Debt) ($) | -- | (4.352B) | (3.906B) | (4.668B) | (1.759B) |
| Net Cash / (Debt) per share ($) | -- | (2.458) | (2.186) | (2.613) | (0.984) |
| Total Debt / Capital Employed (%) | -- | 30.327% | 42.492% | 36.891% | 34.303% |
| Interest Coverage Ratio (X) | -- | 9.581 X | 11.088 X | 10.960 X | 24.004 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | -- | 19.140 Day | 17.827 Day | 15.214 Day | 11.874 Day |
| Receivables Turnover (Day) | -- | 69.216 Day | 65.231 Day | 55.298 Day | 56.523 Day |
| Payables Turnover (Day) | -- | 13.221 Day | 12.948 Day | 12.833 Day | 12.431 Day |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,663,899 |
| %Change | -7.218% |
| EPS / (LPS) | RMB 0.944 |
| NBV Per Share (¥) | RMB -- |